Warning Letter Roundup & Recap – May 17, 2016
This article was originally published in The Gray Sheet
Executive Summary
Premarket authorization problems noted at maker of the Eclipse Micro-Pen Elite device for the treatment of wrinkles. The firm was the only recipient of a device warning letter listed by FDA this week.